Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2025.03.28
海普瑞：2024年度监事会工作报告
2025.02.26
海普瑞：关于依诺肝素钠注射液获得阿根廷药品注册批件的公告
2025.02.18
海普瑞：关于获得药物临床试验批准通知书的公告
2025.02.14
海普瑞：关于获得GMP证书的公告
2025.01.24
海普瑞：2024年度业绩预告
2025.01.02
海普瑞：关于签订分销协议的公告
2024.12.06
海普瑞：关于延长员工持股计划存续期的公告
2024.12.06
海普瑞：第六届董事会第十三次会议决议公告
2024.08.30
海普瑞：2024年半年度报告摘要
2024.07.12
海普瑞：2024年半年度业绩预告
第一页
上一页
2
3
4
5
6
下一页
最后一页
